AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Postoperative Pain Epidemiology Forecast Report 2021-2030 - ResearchAndMarkets.com

July 5, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Jul 5, 2021--

The “Postoperative Pain - Epidemiology Forecast to 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering.

The report covers the detailed information of the Postoperative Pain epidemiology scenario in seven major countries (US, EU5, and Japan).

The Postoperative Pain epidemiology report gives a thorough understanding of the Postoperative Pain by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Postoperative Pain in the US, Europe, and Japan.

ADVERTISEMENT

Postoperative Pain Epidemiology Perspective

The Postoperative Pain epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Postoperative Pain epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM.

The Postoperative Pain epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Postoperative Pain Detailed Epidemiology Segmentation

The Postoperative Pain epidemiology covered in the report provides historical as well as forecasted Postoperative Pain epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The Postoperative Pain report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Report Highlights

  • 11-Year Forecast of Postoperative Pain epidemiology
  • 7MM Coverage
  • Total Cases of Postoperative Pain
  • Total Cases of Postoperative Pain according to segmentation
  • Diagnosed cases of Postoperative Pain

KOL-Views

The publisher interviews, KOLs and SME’s opinion through primary research to fill the data gaps and validate the secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

ADVERTISEMENT

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Postoperative Pain?
  • What are the key findings pertaining to the Postoperative Pain epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Postoperative Pain across the 7MM during the forecast period (2017-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Postoperative Pain?
  • What are the currently available treatments of Postoperative Pain?

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Key Topics Covered:

1 Report Introduction

2 Postoperative Pain Epidemiology Overview at a Glance

2.1 Epidemiology Share (%) Distribution of Postoperative Pain in 2018

2.2 Epidemiology Share (%) Distribution of Postoperative Pain in 2030

3 Executive Summary of Postoperative Pain

4 Disease Background and Overview

4.1 Introduction

4.2 Transition from Acute to Chronic Pain

4.2.1 Elective or Planned Procedures

4.2.2 Common Types of Acute Postoperative Pains

4.3 Pathophysiology of Acute Pain

4.3.1 Formation of reflexes in postoperative pain

4.3.1.1 Segmental reflexes

4.3.1.2 Suprasegmental reflexes

4.3.1.3 Cortical responses

4.3.2 Negative effects of postoperative pain on various organ systems

4.3.2.1 Changes in respiratory functions

4.3.2.2 Cardiovascular changes

4.3.2.3 Gastrointestinal and urinary changes

4.3.2.4 Neuroendocrine and metabolic changes

4.3.3 Psychological effects of postoperative pain

4.3.4 Late effects of insufficient postoperative analgesia

4.3.5 Chronic postoperative pain

4.4 Factors affecting postoperative pain

4.5 Diagnosis of Postoperative Pain

4.5.1 Medical history, physical examination, and specific evaluation of pain

4.5.2 Measuring pain

4.5.3 Various Grading Scales used for Diagnosis of Acute Pain

4.5.3.1 Visual Analogue Scale

4.5.3.2 Verbal Rating Scale

4.5.3.3 Graded Chronic Pain Scale (GCPS)

4.5.3.4 Numeric Rating Scale (NRS)

4.5.4 Verbal methods of pain assessment

4.5.5 Multidimensional methods of pain assessment

4.5.6 Nonverbal methods of pain assessment

4.5.7 Diagnostic Algorithm

4.5.8 Guidelines

4.5.8.1 Guidelines on the Management of Postoperative Pain

4.5.8.2 Goals and Elements of the Initial Assessment

5 Epidemiology and Patient Population

5.1 Key Findings

5.2 Methodology of Epidemiology

5.3 Total number of Incident cases of Postoperative Pain in the 7MM

5.4 Epidemiology of Postoperative Pain in the 7MM

5.5 United States

5.5.1 Total number of surgical procedures in the US

5.5.2 Total number of Incident cases of Postoperative Pain in the US

5.5.3 Severity-specific incident cases of Postoperative Pain in the US

5.6 EU5

5.6.1 Germany

5.6.2 France

5.6.3 Italy

5.6.4 Spain

5.6.5 United Kingdom

5.7 Japan

6 KOL Views

6.1 US KOL Views

6.2 EU5 and Japan KOL Views

7 Appendix

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/enbl4t

View source version on businesswire.com:https://www.businesswire.com/news/home/20210705005139/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HOSPITALS PHARMACEUTICAL HEALTH SURGERY

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 07/05/2021 07:44 AM/DISC: 07/05/2021 07:44 AM

http://www.businesswire.com/news/home/20210705005139/en